Association of Diabetes Care & Education Specialists

JOIN ADCES

AstraZeneca Educational Webinar Series

Presented by ADCES in association with AstraZeneca-US Medical Affairs, CVMD Division

This educational webinar series is designed to provide the most up-to-date, cutting edge information in diabetes. Each webinar will be presented live and recorded. Archived presentations will be posted on this page for up to 90 days after the live broadcast, so don't miss out!

This webinar series is educational in nature and contains no promotional or product information. CE credit is not available for this activity.





Upcoming Live Webinar:


SGLT-2 Inhibitor Overview and Emphasis on Cardio-Renal Axis

Speakers TBA

This webinar will go over how SGLT-2 inhibition impacts the physiology of the kidney and heart. Understand the clinical effects on glycemia, MACE, hHF, and renal endpoints in diabetes, as well as the evolving landscape and use of these agents in patients without diabetes.

Wednesday, December 2, 2020 at 1:00 pm EST

    

  

  


Webinar Recordings

  

Relationship of Type 2 Diabetes and Chronic Kidney Disease: Opportunities for Prevention, Intervention, and Mitigation

Originally presented on September 23, 2020 by Kerry Cooper, MD and Donna Stevens, DNP, FNP-BC, BC-ADM, CDCES

This webinar will give you an understanding of how type 2 diabetes and diabetic kidney disease (DKD) are related. Understand the continuum of disease progression and key points of intervention, as well as the treatment options when treating complications of DKD.

Upon completion of this activity, participants will be able to:

  1. Understand the how T2D and DKD are related
  2. Understand the continuum of disease progression and key points of intervention
  3. Understand the treatment options when treating complications of DKD
                    
     
     

Type 2 Diabetes and Kidney Disease: Patient engagement and how to manage chronic conditions

Originally presented on October 21, 2020 by Ted Okerson, MD, FACP, FACE, FTOS; Kerry Cooper, MD; Susan Guzman, PhD; and Donna Stevens, DNP, FNP-BC,
BC-ADM, CDCES

In this panel discussion, understand key points of clinical intervention, as well as how to engage people with diabetes in discussions about chronic conditions early in development of disease, and how to encourage adopting healthy behaviors.

Upon completion of this activity, participants will be able to:

  1. Understand key points of clinical intervention
  2. Engage people with diabetes in discussions about chronic conditions early in development of disease
  3. Encourage adopting healthy behaviors